FORWARD-LOOKING STATEMENTS

Except for historical information, this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses. Such forward-looking statements include, among others, those statements including the words "expects," "anticipates," "intends," "believes" and similar language. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed herein. You should carefully review the risks described herein and in other documents we file from time to time with the Securities and Exchange Commission. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances after the date of this document.

Although we believe that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements.

All references in this Form 10-Q to the "Company," "we," "us," or "our," are to Med Spa Vacations Inc.





General Overview

We were incorporated in the State of Nevada on October 5, 2015.

On August 22, 2017, each of Blaine Redfern and Morgan Powell, the controlling stockholders of the Company entered into and closed stock purchase and sale transactions pursuant to which they each sold 5,000,000 restricted shares of the common stock, $0.001 par value per share (the "Common Stock"), of the Company, or, in the aggregate, 10,000,000 shares (the "Shares") of the Common Stock being all of the outstanding restricted common stock of the Company, to Mr. Chao Ma. These transactions were completed at a price per share of $0.030320, for an aggregate amount of $303,200, pursuant to the terms of a securities purchase agreement. The Shares represent approximately 69.7% of the Company's issued and outstanding common stock, all of which is voting common stock, as of the closing.

In connection with the closing of the stock purchase transactions discussed above, on August 22, 2017, Blaine Redfern and Morgan Powell, the two directors of the Company, submitted their resignation letters, pursuant to which they each resigned from their positions as directors and from all offices of the Company that they held, effective as of the closing of the stock purchase transactions on August 22, 2017. The resignations of Messrs. Redfern and Powell were not in connection with any known disagreement with the Company on any matter.

On May 22, 2017, Mr. Chao Ma was appointed to the board of the directors, effective as of August 22, 2017 upon the resignations of Messrs. Redfern and Powell. Mr. Ma was also appointed as the President, Treasurer and Secretary of the Company.

Our plan was to develop a business that specializes in marketing health and wellness vacations to both individuals and corporate groups looking to revitalize and develop a fuller day-to-day life. We were looking to establish a niche in the travel market that caters to sustained wellness and rejuvenation, recognizing the ever-increasing social trend toward finding of a more holistic balance in life. We were not successful in our efforts and discontinued that line of business.

On June 20, 2019, Chao Ma, the controlling stockholder of the Company, closed stock purchase and sale transactions pursuant to which he sold an aggregate of 10,000,000 restricted shares of the Company's common stock, $0.001 par value per share, to certain purchasers at a purchase price of $0.035 per share, or an aggregate purchase price of $350,000. One of the Purchasers, Kynson Health Limited, a BVI entity (the "Majority Purchaser"), purchased 9,985,329 of the Shares (the "Majority Shares") for an aggregate purchase price of approximately $349,486 (the "Change of Control Transaction"). Kynson Health Limited is owned 100% by OuYang XingYing, who was appointed as the Company's sole officer and director upon the closing of the Change of Control Transaction. The Majority Purchaser used working capital to acquire the Majority Shares. The Majority Shares purchased by the Majority Purchaser represented approximately 69.6% of the Company's issued and outstanding shares of common stock as of the date of the closing of the Change of Control Transaction. Therefore, the Change of Control Transaction resulted in a change in control of the Company.






          3

  Table of Contents

Going forward, we intend to seek, investigate and, if such investigation warrants, engage in a business combination with a private entity whose business presents an opportunity for our shareholders. No specific assets or businesses have been definitively identified and there is no certainty that any such assets or business will be identified or that any transactions will be consummated.

We have no revenues and limited cash on hand. We have sustained losses since inception. We have never declared bankruptcy, been in receivership, or involved in any kind of legal proceeding.

We do not have any subsidiaries.





Results of Operations

Three-Month Periods Ended September 30, 2019 Compared to Three-Month Period Ended September 30, 2018

Our results of operations for the three-month periods ended September 30, 2019 and 2018 are summarized below:





                        Three Months Ended
                           September 30,
                          2019           2018
Revenue              $            -      $   -
Operating expenses           18,561          -
Net loss             $      (18,561 )    $   -




Revenues and Other Income

During the three-month periods ended September 30, 2019 and 2018, we did not realize any revenues from operations.





Operating Expenses

Operating expenses, consisted entirely of professional fees of $18,561 in the three-month period ended September 30, 2019, compared to $0 in the three-month period ended September 30, 2018. This increase in expenses was primarily attributed to professional fees for maintaining reporting status with the Securities and Exchange Commission ("SEC").

Nine-Month Period Ended September 30, 2019 Compared to Nine-Month Ended September 30, 2018

Our results of operations for the nine-month periods ended September 30, 2019 and 2018 are summarized below:





                        Nine Months Ended
                          September 30,
                          2019          2018
Revenue              $            -     $   -
Operating expenses   $      214,013     $   -
Net loss             $     (214,013 )   $   -





          4

  Table of Contents




Revenues and Other Income

During the nine-month periods ended September 30, 2019 and 2018, we did not realize any revenues from operations.





Operating Expenses

Operating expenses totaled $214,013 in the nine-month period ended September 30, 2019, compared to $0 in the nine-month period ended September 30, 2018. This increase is primarily the result of legal and consulting fees of $162,932 in relation to stock purchase and sale transactions, and audit, accounting, tax and other miscellaneous professional fees of $51,081 associated with becoming current on our SEC filings.





Net Losses

As a result of the foregoing, we incurred a net loss of $214,013, for the nine-months ended September 30, 2019, compared to a net loss of $0 for the corresponding period ended September 30, 2018.

Liquidity and Capital Resources





                             September 30,       December 31,
                                 2019                2018           Change
Cash and cash equivalents   $             -     $       21,500     $ (21,500 )
Total Assets                $             -     $       21,500     $ (21,500 )
Total Liabilities           $        19,436     $       39,113     $ (19,677 )
Stockholders' Equity        $       (19,436 )   $      (17,613 )   $  (1,823 )
Working Capital             $       (19,436 )   $      (17,613 )   $  (1,823 )

As of the date of this report, we had yet to generate any revenues from our business operations.

As of September 30, 2019, we had current assets of $0, we had liabilities of $19,436, and our working capital deficit was $19,436. We anticipate that our current liquidity is not sufficient to meet the obligations associated with being a company that is fully reporting with the SEC.

To date, we have managed to keep our monthly cash flow requirement low for two reasons. First, our sole officer does not draw a salary at this time. Second, we have been able to keep our operating expenses to a minimum by operating in space provided at no expense by one of our shareholders.

We currently have no external sources of liquidity such as arrangements with credit institutions or off-balance sheet arrangements that will have or are reasonably likely to have a current or future effect on our financial condition or immediate access to capital.

Our financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"), which contemplates our continuation as a going concern. We have not yet generated any revenue and have incurred losses to date of $214,013. In addition, our current liabilities exceed our current assets by $19,436. These factors raise substantial doubt about our ability to continue operating as a going concern. Our ability to continue our operations as a going concern, realize the carrying value of our assets, and discharge our liabilities in the normal course of business is dependent upon our ability to raise capital sufficient to fund our commitments and ongoing losses, and ultimately generate profitable operations.





Cash Flows



                                          Nine Months Ended
                                            September 30,
                                          2019          2018

Cash used in operating activities $ (21,500 ) $ (3,500 ) Cash provided by Investing Activities $ - $ - Cash provided by financing activities $ - $ - Net Change In Cash

$ (21,500 )   $ (3,500 )





          5

  Table of Contents




Operating Activities

For the nine months ended September 30, 2019, net cash used in operating activities was $21,500, related to our net loss of $214,013, reduced by an increase in expenses paid by related party of $192,851 and increased by decrease in accounts payable and accrued liabilities of $338.

During the nine months ended September 30, 2019 and September 30, 2018, the Company's sole Director and Officer paid $192,851 and $0, respectively, on behalf of the Company for business operation purpose.





Investing Activities

The Company did not use any funds for investing activities during the nine months ended September 30, 2019 and September 30, 2018.





Financing Activities

The Company did not use any funds for financing activities during the nine months ended September 30, 2019 and September 30, 2018.

Recent Accounting Pronouncements

For a description of our recently issued accounting pronouncements, see "Note 2 - Summary of Significant Accounting Policies" of this Quarterly Report on Form 10-Q.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to select appropriate accounting policies and to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses.

Off-Balance Sheet Arrangements

We have never entered into any off-balance sheet financing arrangements and have not formed any special purpose entities. We have not guaranteed any debt or commitments of other entities or entered into any options on non-financial assets.

© Edgar Online, source Glimpses